Evidence map›Paper›PMID 39400863›Full record

ArticleIrish journal of medical science2025

Patient's barrier to initiate insulin therapy for type 2 D.M.

Ruqaya Adnan Salih, Anmar B Al-Dewachi, Zaid Muayad Yassen, Saad Abdul-Razzak Ibrahim

Abstract read
PubMed Publisher
In one paragraph

Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruqaya Adnan SalihDepartment of Family and Community Medicine/ College of Medicine/ University of Mosul, Mosul, Iraq.ORCID http://orcid.org/0009-0004-5878-7093
Anmar B Al-DewachiDepartment of Family and Community Medicine/ College of Medicine/ University of Mosul, Mosul, Iraq.ORCID http://orcid.org/0000-0002-5613-7300
Zaid Muayad YassenDepartment of Family and Community Medicine/ College of Medicine/ University of Mosul, Mosul, Iraq. zaidyassen67@yahoo.com.ORCID http://orcid.org/0000-0003-1713-1587
Saad Abdul-Razzak IbrahimMosul Cardiac Center / Ninevah Health Directorate, Mosul, Iraq.ORCID http://orcid.org/0009-0006-8480-4437

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes Mellitus is a health challenging of the century, more than 300 million people lives with diabetes, and it is one of the biggest global health concerns, awing to its complications. Good glycemic control is the cornerstone to decrease risk of type 2 diabetes complications. Even though, many people still have poor glycemic control which can be partly attributed to late insulin initiation, that can be challenging and forced by numbers of barriers. Identification and analysis of these barriers is crucial to find out effective way to overcome them.

aimTo assess patient's barriers to initiate insulin therapy among diabetic patients.

methodA case series study was conducted during the period extending from July 2023 to June 2024, and a total of 360 participants with type two diabetes were included in this study from four Family Medicine Health Centers. Collected data tabulated and analyzed using Excel sheets and applying the Statistical Package for the Social Sciences (SPSS) Version 24.

results26% of the participants were 45-55 years age group, 40% has been diagnosed with diabetes for 5-10 years, and 66% have developed diabetic complications. Fear from hypoglycemia was the comments barrier to initiate insulin therapy and is seen in 84% of the participants.

conclusionMany barriers have been identified to influence the initiation of insulin therapy, fear from hypoglycemia was found to be the most influencing barrier. Increasing patient's awareness of symptoms of hypoglycemia, and always take their meal after insulin injection can help to overcome hypoglycemia.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsInsulinAdultAgedFemaleHumansHypoglycemiaMaleMiddle AgedHypoglycemic AgentsInsulinBarrierHypoglycemiaInsulinType 2 diabetes

Identifiers

PMID39400863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.